安若维他

Aurovitas Pharma Taizhou Co., Ltd. (安若维他) is a wholly-owned subsidiary of Aurobindo Pharma, one of India's largest listed pharmaceutical companies and a global leader in generic drugs. Established in January 2018 in China Medical City (Taizhou), the company specializes in the research, development, and large-scale commercial manufacturing of oral solid dosages, including tablets and hard capsules. Its state-of-the-art facility features advanced quality control laboratories and high-capacity production lines designed to meet both Chinese and international GMP standards. Aurovitas Pharma Taizhou focuses on bringing high-quality, affordable chemical generic drugs to the Chinese market and exporting to global markets, covering therapeutic areas such as cardiovascular health, gastroenterology, neurology, and infectious diseases.